查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1837245

血栓切除器械市場（按器械、手術、技術、分銷管道和最終用戶分類）—2025-2032年全球預測

Thrombectomy Devices Market by Device, Procedure, Technology, Distribution Channel, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，血栓切除裝置市場將成長至 33 億美元，複合年成長率為 7.64%。

關鍵市場統計數據
基準年2024年 18.3億美元
預計年份：2025年 19.7億美元
預測年份 2032 33億美元
複合年成長率 (%) 7.64%

在器械工程、影像融合技術的進步以及臨床證據的不斷累積的推動下，血栓切除器械已從小眾介入治療轉變為多種急性血管疾病治療路徑中不可或缺的工具。本文概述了目前血栓切除術的現狀：臨床醫生、醫院系統和專科中心越來越依賴快速的機械方法和多學科協作來清除腦、靜脈和肺循環中的阻塞性血栓。隨著器械技術的不斷發展，不同手術類型和技術模式之間的界限也日益模糊，從而促進了神經介入醫師、血管外科醫師和介入放射科醫師之間的跨學科合作。

因此，醫療器材的採購和使用決策不再僅基於成本或品牌知名度。相反，臨床結果數據、在混合手術環境中的易用性、供應商提供的培訓支援以及供應的連續性才是關鍵決定因素。同時，監管機構也完善了醫療器材核准和上市後監測流程，更重視實際應用性能指標。綜上所述，這些變化凸顯了相關人員需要將臨床需求與營運彈性相結合，以適應不同醫療保健系統對快速再灌注治療和標準化診療路徑日益成長的需求。

技術創新在設備設計、影像整合和診療路徑最佳化方面的融合如何重塑醫療機構的臨床應用和投資格局

血栓切除器械領域正經歷變革性的轉變，這主要得益於技術創新、手術流程標準化以及醫療系統對速度和療效的重視。小型化和材料科學的進步提高了器械在複雜血管解剖結構中的可追蹤性和輸送性，而新的設計則拓展了抽吸技術和支架取栓平台的治療範圍。同時，影像技術和術中導航系統的日益成熟，使得器械定位更加精準，手術時間也得以縮短。

監管和報銷環境也在不斷變化，越來越多的支付方認知到及時進行機械再灌注治療對中風和肺栓塞病例的後續成本效益。這些變化獎勵醫療機構投資於培訓、混合手術室設施和流程最佳化，以最大限度地提高首次治療的成功率。此外，醫療器材製造商和臨床網路之間的合作日益密切，旨在透過結構化的培訓項目，產生可靠的真實世界證據並加速技術應用。因此，目前的技術應用模式反映了技術創新應用曲線與庫存管理、人員能力以及與急診治療路徑的契合度等實際因素之間的平衡。

評估新實施的關稅對血栓切除器械相關人員的供應鏈、籌資策略和總成本的多方面影響

美國將於2025年實施新的關稅，這為本已錯綜複雜的血栓切除器械全球供應鏈增添了新的複雜性。雖然這些關稅旨在保護國內製造業和戰略產業，但也改變了依賴跨境生產專用零件和原料的公司的成本結構。在關鍵市場擁有垂直整合供應鏈的製造商能夠更好地吸收或緩解關稅帶來的成本壓力，而依賴受影響地區單一供應商的公司則面臨採購穩定性的下降。

為此，許多相關人員加快了主動風險管理措施的實施，包括供應商多元化、將關鍵生產環節遷回國內以及重新談判長期合約以確保有利條款。經銷商和醫院採購團隊都加強了庫存計劃，以防止在過渡性關稅實施期間出現短期缺貨。重要的是，籌資策略的重點從單純的單位成本轉向評估總體擁有成本，並考慮了前置作業時間可預測性、保固和服務以及培訓支援等因素。展望未來，關稅的累積影響使得策略性供應鏈韌性成為醫療器材製造商和醫療保健系統持續獲得關鍵血栓清除技術的核心競爭優勢。

全面的細分分析揭示了設備類別、手術亞型、技術方法、分銷策略和醫療環境如何驅動臨床和商業優先事項。

細緻的市場細分視角揭示了器械選擇、手術適應症、底層技術、分銷管道以及終端用戶偏好如何塑造市場動態和臨床工作流程。依器械類型分類，市場可分為抽吸導管和血栓摘取支架，二者在輸送性、血栓累及程度及預期首過療效方面各有不同。臨床醫師會根據病變形態、血管通路複雜度和操作者熟練程度選擇合適的器械。依手術類型分類，血栓切除術的應用涵蓋深層靜脈栓塞症、缺血性中風和肺動脈栓塞。深層靜脈栓塞症形成可分為遠端深部靜脈血栓形成和髂股深部靜脈血栓形成，缺血性中風可分為閉塞前和閉塞後，肺動脈栓塞可分為高容量肺栓塞和低容量肺栓塞。這些手術類型決定了具體的器械設計重點、輔助技術以及所需的臨床醫生技能。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 雙機制抽吸和支架取栓裝置在綜合中風治療的應用日益廣泛
  • 加強人工智慧驅動的影像和即時分析的整合，以最佳化血栓切除術的效果
  • 對用於遠端血管再通的可導航導管設計的需求日益成長
  • 擴展可攜式和移動式介入治療設備，以便在現場實現快速中風介入治療。
  • 開發可生物分解和藥物釋放型洗脫血栓切除裝置以降低再閉塞率
  • 引入機器人導管引導系統，以提高複雜顱內手術的精確度
  • 醫療器材製造商與遠距中風醫療網路建立策略夥伴關係，以支援遠距手術

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 血栓切除器械市場：依器械分類

  • 吸管
  • 支架取栓器

9. 依手術類型分類的血栓切除器械市場

  • 深層靜脈栓塞症
    • 遠端
    • 髂骨和股骨
  • 缺血性中風
    • 前循環
    • 後循環
  • 肺動脈栓塞
    • 大規模
    • 半大型

第10章 血栓切除器械市場：依技術分類

  • 雷射輔助
  • 機器
  • 藥理機制

第11章 血栓切除器械市場（依通路分類）

  • 直銷
  • 線上平台

第12章 依最終用戶分類的血栓切除器械市場

  • 門診手術中心
  • 醫院
  • 專科診所

第13章 血栓切除器械市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 血栓切除器械市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國血栓切除器材市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Penumbra, Inc.
    • Stryker Corporation
    • Medtronic plc
    • Boston Scientific Corporation
    • Terumo Corporation
    • Koninklijke Philips NV
    • Johnson & Johnson
    • Becton, Dickinson and Company
    • Abbott Laboratories
    • AngioDynamics, Inc.
Product Code: MRR-030298DFFFC6

The Thrombectomy Devices Market is projected to grow by USD 3.30 billion at a CAGR of 7.64% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.83 billion
Estimated Year [2025] USD 1.97 billion
Forecast Year [2032] USD 3.30 billion
CAGR (%) 7.64%

Thrombectomy devices have moved from niche interventions to essential tools across several acute vascular care pathways, driven by advances in device engineering, imaging integration, and accumulated clinical evidence. This introduction frames the contemporary landscape where clinicians, hospital systems, and specialty centers increasingly rely on rapid mechanical and combined approaches to remove occlusive thrombi in cerebral, venous, and pulmonary circulations. As device profiles evolve, the boundary between procedure types and technology modalities has become more fluid, prompting interdisciplinary collaboration among neurointerventionalists, vascular surgeons, and interventional radiologists.

Consequently, procurement and utilization decisions are no longer based solely on device cost or brand familiarity. Instead, clinical outcomes data, ease of use in hybrid operating environments, vendor support for training, and supply continuity are central determinants. In parallel, regulatory agencies have refined pathways for device clearance and post-market surveillance, placing greater emphasis on real-world performance metrics. Taken together, these dynamics underscore the need for stakeholders to reconcile clinical imperatives with operational resilience, as the sector adapts to heightened demand for rapid reperfusion therapies and standardized care pathways across diverse health systems.

How converging innovations in device design, imaging integration, and care pathway optimization are reshaping clinical adoption and institutional investments

The landscape for thrombectomy devices is undergoing transformative shifts driven by convergence of technological innovation, procedural standardization, and health system priorities that emphasize speed and outcomes. Miniaturization and material science advances have improved trackability and deliverability in complex vascular anatomy, while novel designs have expanded the therapeutic envelope for aspiration techniques and stent retriever platforms. Simultaneously, imaging modalities and intra-procedural guidance systems have matured, enabling more precise device placement and shorter procedure times, which together support better clinical outcomes and broaden appropriate use criteria.

Regulatory and reimbursement environments are also evolving, with payers increasingly recognizing the downstream cost benefits of timely mechanical reperfusion for stroke and selected pulmonary embolism cases. This shift incentivizes institutions to invest in targeted training, hybrid suite capabilities, and process optimization to maximize first-pass success. Moreover, the industry has seen accelerated collaboration between device manufacturers and clinical networks to generate robust real-world evidence and to speed adoption through structured training programs. As a result, adoption patterns now reflect a balance between innovation adoption curves and pragmatic considerations such as inventory management, staff competencies, and alignment with acute care pathways.

Assessing the multifaceted consequences of newly implemented tariffs on supply chains, procurement strategies, and total cost considerations across thrombectomy device stakeholders

The imposition of new United States tariffs in 2025 introduced a fresh layer of complexity to an already intricate global supply chain for thrombectomy devices. While tariffs aim to protect domestic manufacturing and strategic industries, they have also altered cost structures for companies that rely on cross-border production of specialized components and raw materials. Manufacturers with vertically integrated supply chains in key markets have been better positioned to absorb or mitigate tariff-related cost pressures, whereas firms dependent on single-source suppliers in affected jurisdictions have faced increased procurement volatility.

In response, many stakeholders accelerated active risk management measures including supplier diversification, onshoring of critical production stages, and renegotiation of long-term contracts to secure favorable terms. Distributors and hospital purchasing teams likewise intensified inventory planning to prevent short-term shortages during transitional tariff implementation periods. Importantly, procurement strategies shifted toward evaluating total cost of ownership rather than unit pricing alone, considering factors such as lead time predictability, warranty and service provision, and training support. Going forward, the cumulative impact of tariffs has elevated strategic supply chain resilience to a core competitive attribute for device manufacturers and for health systems seeking uninterrupted access to critical thrombectomy technologies.

Comprehensive segmentation analysis revealing how device class, procedural subtype, technological approach, distribution strategy, and care setting determine clinical and commercial priorities

A nuanced segmentation lens reveals how device choice, procedural indication, underlying technology, distribution approach, and end-user setting collectively shape market dynamics and clinical workflows. Based on device, the market divides into aspiration catheters and stent retrievers, each with distinct profiles for deliverability, clot engagement, and first-pass effect expectations; clinicians select between these device classes according to lesion morphology, vascular access complexity, and operator familiarity. Based on procedure, thrombectomy applications span deep vein thrombosis, ischemic stroke, and pulmonary embolism, with further clinical granularity where deep vein thrombosis is characterized by distal versus iliofemoral presentations, ischemic stroke is classified into anterior circulation versus posterior circulation occlusions, and pulmonary embolism is assessed as massive or submassive cases; these procedural subtypes drive specific device design priorities, adjunctive technologies, and requisite clinician skill sets.

Based on technology, laser assisted, mechanical, and pharmacomechanical approaches provide differentiated mechanisms for thrombus removal or modification, and the choice between them reflects trade-offs among efficacy, procedural duration, bleeding risk, and adjunctive anticoagulation needs. Based on distribution channel, manufacturers and suppliers balance direct sales relationships against online platforms that facilitate expedited procurement and broader geographic reach, influencing training models and post-sale service expectations. Based on end user, ambulatory surgical centers, hospitals, and specialty clinics each impose different operational constraints and purchasing behaviors, where ambulatory settings prioritize streamlined procedural throughput, hospitals emphasize comprehensive on-call coverage and hybrid suites, and specialty clinics focus on subspecialized expertise and case mix. Together, these segmentation dimensions determine product development roadmaps, clinical education investments, and commercialization strategies that align with the procedural mix and care delivery context.

Regional differentiation in clinical infrastructure, regulatory regimes, and adoption drivers shaping tailored commercialization and training approaches across global markets

Regional dynamics vary significantly, with each geography presenting unique clinical practice patterns, regulatory frameworks, and infrastructure maturity that influence device adoption and support models. In the Americas, well-established acute stroke networks, substantial hospital investment in hybrid interventional suites, and concentrated centers of excellence drive demand for high-performance thrombectomy platforms and integrated training programs. Reimbursement structures and emergency medical services protocols in several countries in the region also prioritize rapid triage and transfer pathways, which has a direct bearing on device selection and stocking philosophies at tertiary centers.

Europe, Middle East & Africa presents a heterogeneous landscape where advanced urban centers exhibit rapid uptake of novel thrombectomy technologies while rural and resource-constrained areas face access challenges. Regulatory harmonization efforts in some European jurisdictions streamline market entry for devices, but divergent procurement rules and national health system priorities necessitate differentiated commercialization strategies. In the Asia-Pacific region, rapid investment in stroke care infrastructure and increased procedural volumes in major markets have stimulated local manufacturing partnerships and regional distribution networks. However, variability in clinical training capacity and uneven availability of hybrid environments require tailored educational outreach and flexible service models to support sustained adoption across diverse hospital systems.

How manufacturers are combining iterative device innovation, evidence generation, and expanded service models to strengthen clinical adoption and competitive differentiation

Key companies in the thrombectomy device arena are navigating a landscape defined by rapid innovation, heightened clinical expectations, and supply chain recalibration. Industry leaders are prioritizing investments in product portfolios that enhance first-pass success, facilitate access in tortuous anatomy, and reduce procedural time. Many firms are pursuing iterative device improvements and modular systems that integrate with imaging platforms and offer seamless compatibility with ancillary tools. Strategic alliances between device innovators and imaging or navigation providers have become more commonplace as companies seek to create comprehensive procedural ecosystems that deliver measurable clinical advantages.

Competitive positioning is also influenced by approaches to clinical evidence generation and post-market surveillance. Companies that invest in robust multicenter registries, investigator-initiated trials, and clinician training programs tend to accelerate credibility among high-volume centers and referral networks. In parallel, smaller, more nimble entrants are focusing on niche innovations or cost-efficient manufacturing approaches to address specific procedural gaps or resource-constrained environments. Across the spectrum, manufacturers are enhancing service offerings including hands-on training, simulation curricula, and remote proctoring, recognizing that after-sales support and clinician confidence are pivotal to sustained device utilization.

Actionable strategies for manufacturers, clinicians, and health systems to align product innovation, training, and supply resilience with sustainable clinical and commercial outcomes

Industry leaders should prioritize a coordinated strategy that aligns product development with demonstrated clinical value, operational workflows, and supply chain resilience. First, design efforts must concentrate on improving procedural efficiency and versatility, ensuring devices perform reliably across the key procedural presentations clinicians encounter. Manufacturers and clinical leaders should co-develop training curricula and simulation-based proficiency programs to shorten the learning curve and support diffusion across hospitals and specialty centers. In parallel, investment in robust real-world evidence generation and registry participation will reinforce clinical trust and inform guideline incorporation.

Operationally, organizations must diversify sourcing and consider selective onshoring or dual-sourcing for critical components to mitigate tariff and geopolitical risks. Distribution strategies should blend direct engagement with high-volume centers and digital procurement channels for broader market reach, while maintaining strong after-sales service capabilities. Health systems and procurement teams should adopt total cost of ownership frameworks to evaluate vendor proposals, factoring in service, training, and inventory predictability. Finally, collaboration between manufacturers, payers, and clinical networks to demonstrate value-based outcomes will support sustainable access and appropriate reimbursement pathways, thereby aligning incentives across the care continuum.

Methodological overview detailing a triangulated approach of expert interviews, regulatory and clinical literature review, and cross-validated data synthesis to ensure robust insights

This analysis synthesizes insights derived from a triangulated research methodology that combines primary qualitative engagements with clinical and procurement experts, detailed review of regulatory filings and device labeling, and examination of peer-reviewed clinical literature and procedure registries. Primary research included structured interviews with interventionalists, vascular specialists, hospital supply managers, and industry executives to capture operational challenges, adoption barriers, and real-world device performance considerations. Secondary sources encompassed regulatory approval summaries, published clinical trials, conference proceedings, and white papers that document procedural outcomes, device-specific metrics, and practice guidelines.

Data integrity was assured through cross-validation across multiple information streams, reconciliation of divergent perspectives, and rigorous source attribution. Analytical techniques included thematic synthesis of interview data, technology readiness assessments, and supply chain risk mapping. Limitations of the methodology are acknowledged, including variable transparency in proprietary commercial agreements and the evolving nature of post-market surveillance data. To mitigate these constraints, the research incorporated sensitivity checks and sought corroboration from independent clinical experts to ensure balanced interpretation of trends and strategic implications.

Strategic synthesis emphasizing the interplay of innovation, evidence generation, and operational resilience as determinants of long-term success for thrombectomy stakeholders

In conclusion, thrombectomy devices occupy an increasingly central role across acute vascular care, propelled by device innovation, enhanced imaging integration, and the institutional imperative to deliver timely reperfusion. Stakeholders must adapt to a complex operating environment where procedural variability, regulatory nuance, and supply chain dynamics intersect. Strategic success will hinge upon aligning product capabilities with clinician needs, strengthening evidence generation, and ensuring operational resilience through diversified sourcing and sophisticated distribution strategies.

Looking ahead, organizations that marry technological excellence with comprehensive training and reliable post-sale support will be best positioned to capture long-term clinical trust and utilization. Equally important is the recognition that collaborative efforts among manufacturers, health systems, and payers to demonstrate meaningful patient outcomes will accelerate appropriate access and integration of thrombectomy therapies across broader care pathways. This synthesis should inform executive decision-making, guiding prioritization of investments that balance near-term operational imperatives with sustained clinical impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of dual-mechanism aspiration and stent retriever devices for comprehensive stroke care
  • 5.2. Increasing integration of AI-driven imaging and real-time analytics for optimized thrombectomy outcomes
  • 5.3. Growth in demand for catheter designs with enhanced navigability for distal vessel recanalization
  • 5.4. Expansion of portable and mobile interventional suites enabling rapid on-site stroke interventions
  • 5.5. Development of biodegradable and drug-eluting thrombectomy devices to reduce reocclusion rates
  • 5.6. Adoption of robotic catheter guidance systems to improve precision in complex intracranial procedures
  • 5.7. Strategic partnerships between device manufacturers and telestroke networks for remote procedure support

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Thrombectomy Devices Market, by Device

  • 8.1. Aspiration Catheters
  • 8.2. Stent Retrievers

9. Thrombectomy Devices Market, by Procedure

  • 9.1. Deep Vein Thrombosis
    • 9.1.1. Distal
    • 9.1.2. Iliofemoral
  • 9.2. Ischemic Stroke
    • 9.2.1. Anterior Circulation
    • 9.2.2. Posterior Circulation
  • 9.3. Pulmonary Embolism
    • 9.3.1. Massive
    • 9.3.2. Submassive

10. Thrombectomy Devices Market, by Technology

  • 10.1. Laser Assisted
  • 10.2. Mechanical
  • 10.3. Pharmacomechanical

11. Thrombectomy Devices Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Online Platforms

12. Thrombectomy Devices Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals
  • 12.3. Specialty Clinics

13. Thrombectomy Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Thrombectomy Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Thrombectomy Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Penumbra, Inc.
    • 16.3.2. Stryker Corporation
    • 16.3.3. Medtronic plc
    • 16.3.4. Boston Scientific Corporation
    • 16.3.5. Terumo Corporation
    • 16.3.6. Koninklijke Philips N.V.
    • 16.3.7. Johnson & Johnson
    • 16.3.8. Becton, Dickinson and Company
    • 16.3.9. Abbott Laboratories
    • 16.3.10. AngioDynamics, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. THROMBECTOMY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. THROMBECTOMY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. THROMBECTOMY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DISTAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DISTAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DISTAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DISTAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DISTAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DISTAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ILIOFEMORAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ILIOFEMORAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ILIOFEMORAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ILIOFEMORAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ILIOFEMORAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ILIOFEMORAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ANTERIOR CIRCULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ANTERIOR CIRCULATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ANTERIOR CIRCULATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ANTERIOR CIRCULATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ANTERIOR CIRCULATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ANTERIOR CIRCULATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY POSTERIOR CIRCULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY POSTERIOR CIRCULATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY POSTERIOR CIRCULATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY POSTERIOR CIRCULATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY POSTERIOR CIRCULATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY POSTERIOR CIRCULATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY MASSIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY MASSIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY MASSIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY MASSIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY MASSIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY MASSIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY SUBMASSIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY SUBMASSIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY SUBMASSIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY SUBMASSIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY SUBMASSIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY SUBMASSIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY LASER ASSISTED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY LASER ASSISTED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY LASER ASSISTED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY LASER ASSISTED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY LASER ASSISTED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY LASER ASSISTED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY MECHANICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY MECHANICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY MECHANICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY MECHANICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY MECHANICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY MECHANICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PHARMACOMECHANICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PHARMACOMECHANICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PHARMACOMECHANICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PHARMACOMECHANICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PHARMACOMECHANICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PHARMACOMECHANICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ONLINE PLATFORMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ONLINE PLATFORMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ONLINE PLATFORMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ONLINE PLATFORMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 141. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 145. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 147. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 158. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 160. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 162. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 164. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 166. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 168. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 170. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 176. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 178. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 180. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 182. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 184. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 186. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 188. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 230. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 232. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 234. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 236. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 238. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 248. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 249. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 250. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 251. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 252. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 253. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 254. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 255. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 256. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 259. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 260. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 261. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 283. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 286. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 287. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 288. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 289. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 290. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 291. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 292. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 293. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 294. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 295. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 296. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 297. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 298. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 299. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 300. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 301. GCC THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. GCC THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. GCC THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 304. GCC THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 305. GCC THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 306. GCC THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 307. GCC THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 308. GCC THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 309. GCC THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 310. GCC THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 311. GCC THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 312. GCC THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 313. GCC THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 314. GCC THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 315. GCC THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 316. GCC THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 317. GCC THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 318. GCC THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 319. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 321. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 323. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 324. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 325. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 326. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 327. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 201